{"title":"抗凝血剂合成方法的研究","authors":"Y. Ren, C. Du","doi":"10.1109/ICBEB.2012.441","DOIUrl":null,"url":null,"abstract":"This paper summarizes existing anticoagulants mainly from synthesis methods perspective. It covers traditional anticoagulants such as low molecular weight heparins, warfarin, as well as new anticoagulants like argatroban, rivaroxaban, apixaban and direct thrombin inhibitors dabigatran etexilate. This paper also looks forward to future novel anticoagulants using dabigatran etexilate as a lead compound.","PeriodicalId":6374,"journal":{"name":"2012 International Conference on Biomedical Engineering and Biotechnology","volume":"113 1","pages":"622-625"},"PeriodicalIF":0.0000,"publicationDate":"2012-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Research on Synthesis Methods of Anticoagulants\",\"authors\":\"Y. Ren, C. Du\",\"doi\":\"10.1109/ICBEB.2012.441\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This paper summarizes existing anticoagulants mainly from synthesis methods perspective. It covers traditional anticoagulants such as low molecular weight heparins, warfarin, as well as new anticoagulants like argatroban, rivaroxaban, apixaban and direct thrombin inhibitors dabigatran etexilate. This paper also looks forward to future novel anticoagulants using dabigatran etexilate as a lead compound.\",\"PeriodicalId\":6374,\"journal\":{\"name\":\"2012 International Conference on Biomedical Engineering and Biotechnology\",\"volume\":\"113 1\",\"pages\":\"622-625\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-05-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"2012 International Conference on Biomedical Engineering and Biotechnology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1109/ICBEB.2012.441\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"2012 International Conference on Biomedical Engineering and Biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/ICBEB.2012.441","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Research on Synthesis Methods of Anticoagulants
This paper summarizes existing anticoagulants mainly from synthesis methods perspective. It covers traditional anticoagulants such as low molecular weight heparins, warfarin, as well as new anticoagulants like argatroban, rivaroxaban, apixaban and direct thrombin inhibitors dabigatran etexilate. This paper also looks forward to future novel anticoagulants using dabigatran etexilate as a lead compound.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
